BD COR™ System
High‑Throughput Automation Without Compromise. The BD COR™ System is a fully automated, high‑throughput molecular solution designed to scale routine testing while protecting staff time and lab resilience. The BD COR™ System offers innovative HPV testing that keeps up with evolving guidelines and patient needs with BD Onclarity™ HPV assay with at-home self-collection.*
Long Description
We know almost all cervical cancers are caused by HPV.1 Progress towards eliminating cervical cancer starts by elevating the standard of screening: · Extended genotyping is increasingly important in a post-vaccine world where HPV 16/18 infections have declined as much as 90%.2 · 81% of women want a less invasive HPV testing option.3 Barriers like limited access and anxiety keep many women from getting screened. When it comes to screening, partial HPV genotyping risks masking cancer-causing genotypes behind a grouped result. Plus, diagnostic barriers can impact the ability for patients to access screening. That’s why choosing the BD Onclarity™ HPV Assay with extended genotyping† and a self-collection* option is essential. · Break care barriers: Help boost HPV screening rates with an accessible and private self-collection* option. · Make precise care decisions: Manage patient risk with reporting of more individual high-risk HPV genotypes beyond HPV 16,18 and 45
High Resolution Image
Small Image
Large Image
Category Product Showcase